. . . . . . "72024"^^ . . "26466154"^^ . . . . . . . . . . "220"^^ . "11"^^ . . . . . . . . . . . . . . . . . . "6X8764TW2J" . . . . . "95847"^^ . . "72024" . . . . "none"@en . "18"^^ . "5"^^ . "3"^^ . . "21"^^ . . . . . "Revospirone (Bay Vq 7813) is an azapirone drug which was patented as a veterinary tranquilizer but was never marketed. It acts as a selective 5-HT1A receptor partial agonist. Similarly to other azapirones such as buspirone, revospirone produces 1-(2-pyrimidinyl)piperazine (1-PP) as an active metabolite. As a result, it also acts as an \u03B12-adrenergic receptor antagonist to an extent."@en . . . . . . "2239"^^ . . "95847-87-3" . . "6"^^ . . . . . . . "65018"^^ . . . . "1"^^ . . . . "Revospirone (Bay Vq 7813) is an azapirone drug which was patented as a veterinary tranquilizer but was never marketed. It acts as a selective 5-HT1A receptor partial agonist. Similarly to other azapirones such as buspirone, revospirone produces 1-(2-pyrimidinyl)piperazine (1-PP) as an active metabolite. As a result, it also acts as an \u03B12-adrenergic receptor antagonist to an extent."@en . . "1119925169"^^ . . . . "Revospirone"@en . . . . .